ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Oral vitamin C supplementation in patients with clonal cytopenia of undetermined significance or lower‐risk myeloid malignancies: Results from EVITA, a phase 2 randomized, placebo‐controlled trial

Study limitation reported by the research below: “The overall survival benefit is a post hoc exploratory endpoint; the trial was neither powered nor designed to assess survival, so the finding (HR 0.35) should be interpreted as hypothesis-generating only.”

Papers